| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.34 | 7e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |